These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1570298)

  • 1. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals.
    Algiman M; Dietrich G; Nydegger UE; Boieldieu D; Sultan Y; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3795-9. PubMed ID: 1570298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
    Sultan Y; Rossi F; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):828-31. PubMed ID: 3101065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.
    Batlle J; Gómez E; Rendal E; Torea J; Lourés E; Couselo M; Vila P; Sedano C; Tusell X; Magallón M; Quintana M; González-Boullosa R; López-Fernández MF
    Ann Hematol; 1996 May; 72(5):321-6. PubMed ID: 8645745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg).
    Dietrich G; Algiman M; Sultan Y; Nydegger UE; Kazatchkine MD
    Blood; 1992 Jun; 79(11):2946-51. PubMed ID: 1586740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG.
    Moreau A; Lacroix-Desmazes S; Stieltjes N; Saenko E; Kaveri SV; D'Oiron R; Sultan Y; Scandella D; Kazatchkine MD
    Blood; 2000 Jun; 95(11):3435-41. PubMed ID: 10828026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides.
    Di Giambattista M; Branckaert T; Laub R
    Biologicals; 2001; 29(3-4):229-32. PubMed ID: 11851320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells.
    Cormier M; Burnett E; Mo A; Notley C; Tijet N; Christie-Holmes N; Hough C; Lillicrap D
    J Thromb Haemost; 2024 Jan; 22(1):76-89. PubMed ID: 37678547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized severe combined immunodeficient mice as a potential model for the study of tolerance to factor VIII.
    Vanzieleghem B; Gilles JG; Desqueper B; Vermylen J; Saint-Remy JM
    Thromb Haemost; 2000 Jun; 83(6):833-9. PubMed ID: 10896234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to factor VIII.
    Lacroix-Desmazes S; Misra N; Bayry J; Mohanty D; Kaveri SV; Kazatchkine MD
    Autoimmun Rev; 2002 Feb; 1(1-2):105-10. PubMed ID: 12849066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
    Hausl C; Maier E; Schwarz HP; Ahmad RU; Turecek PL; Dorner F; Reipert BM
    Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction.
    Gilles JG; Arnout J; Vermylen J; Saint-Remy JM
    Blood; 1993 Oct; 82(8):2452-61. PubMed ID: 7691260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG; Saint-Remy JM
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting.
    Fulcher CA; de Graaf Mahoney S; Zimmerman TS
    Blood; 1987 May; 69(5):1475-80. PubMed ID: 2436689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.